Crescita Therapeutics Inc. announced that, the company appointed Jose DaRocha as Chief Financial Officer effective November 7, 2017. Mr. DaRocha is a Chartered Professional Accountant and is an accomplished finance executive with over 25 years of experience with increasing levels of responsibility in multinational public corporations in both the cosmetic and pharmaceutical industries. His track-record includes finance, accounting and reporting, business development and financial systems implementations. The Company thanked Ms. Muneerah Kanji, MBA, CPA, CA, for all her contributions and efforts during her tenure with the Company as Interim CFO.